细胞信号转导与可变剪接调控

大多数真核基因能够发生可变剪接,其调控对于生理和病理状态下细胞功能的实现至关重要,而异常可变剪接则可导致多种疾病。虽然已知可变剪接能够在转录后水平调节基因表达,然而目前仍不清楚特定的可变剪接模式是如何被调控的。越来越多的研究发现细胞信号和外界环境刺激能够调控靶基因的剪接模式,并且已发现一些与可变剪接调控有关的信号转导通路,而后者能够通过修饰剪接因子进而改变剪接因子的亚细胞定位或者活性,从而实现对靶基因可变剪接模式的调控。由细胞信号转导通路所构成的网络能够灵活多样地调控基因剪接,一条信号通路可调控多个基因剪接,而多条信号通路也可调控同一基因剪接,对于理解信号转导过程的分子机制具有重要意义。     

真核基因可变剪接研究现状与展望

mRNA前体(pre-mRNA)的可变剪接是控制基因表达和产生蛋白质多样性的重要机制,是功能基因组时代的研究重点之一。生物信息学在识别可变剪接基因及其结构、分析可变剪接的功能和调控方式等方面具有重要作用。除了耗时的实验研究,识别可变剪接基因及其结构主要通过EST、mRNA等转录数据与基因组序列进行比对,获得同一基因的不同结构方式。分析蛋白质产物可对可变剪接的功能进行预测;潜在调控元件的统计分析则可为可变剪接调控机制的研究提供必要的数据。转录数据的时空信息以及比较基因组学对理解可变剪接信息的精确调控将提供重要资料。可变剪接及其调控机制的深入研究将为基因组和蛋白质组之间的对接提供重要的桥梁。     

可变剪接在植物免疫中的研究进展

可变剪接是生物重要的转录后修饰过程,是转录组和蛋白组多样性的重要来源.可变剪接参与了植物众多生理过程,包括植物昼夜节律、生长发育等,在植物响应生物和非生物胁迫过程中尤为普遍.近年来,可变剪接被认为是植物抵御病原菌侵染的重要调控机制.本文综述了可变剪接在植物免疫各个层面的调控作用,包括调节重要免疫受体、R基因、激素信号路...     

拟南芥不同组织基因表达及可变剪接差异分析

可变剪接是转录后重要的基因表达调控方式,也是转录组和蛋白质组多样性的重要来源. 近年来随着拟南芥、水稻、玉米等植物转录组测序的完成,研究人员发现植物pre-mRNA可变剪接的发生与组织分化、发育等生物学过程密切相关. 本工作基于GEO数据库的RNA-seq数据,使用高通量测序数据分析常用的Trimmomatic、Salmon、DESeq2、SUPPA2等工具,识别了拟南芥的种子、根、叶、花、花梗、节间、长角果共7种组织的表达基因和可变剪接事件,以及7种组织间的差异表达基因和差异可变剪接事件,并以叶和花为例展示了相应的生物学功能分析. 该工作系统地研究了拟南芥基因表达和可变剪接发生的组织特异性,有助于进一步阐明植物基因组的基因表达调控机制.     

可变剪接调控植物开花的作用机制进展

开花是植物生长发育的关键转折,与种子生产和作物产量密切相关。开花转变受到复杂的基因网络调控,许多开花相关基因通过可变剪接产生多种转录本,调控开花时间。文中从多个角度系统地综述了可变剪接调控植物开花的分子机制,并对将来的研究进行了展望。     

选择性剪接的理论预测

可变剪接作为真核生物转录后加工机制普遍存在于不同组织、不同发育时期或不同病理状态下的基因表达调控过程中。对同一基因不同剪接变体的研究可使我们更深入的了解发育、进化、疾病发生机理等基本的生物学问题。讨论了一些基于序列比对而建立的可变剪接的理论预测方法,尚存不足之处,有待于进一步完善。     

RNA的可变剪接对肿瘤生物学的影响

可变剪接是真核生物基因的重要调控机制,同一基因通过不同的剪接方式可以生成不同的蛋白质。肿瘤是一种多因素作用的复杂疾病,越来越多的研究证实可变剪接在肿瘤的发生、发展中扮演着重要的角色。本文结合最新的肿瘤学综述总结出来肿瘤基本特征,及其与基因的可变剪接密切联系,进而探讨可变剪接对肿瘤生物学的影响。     

染色质结构与mRNA可变剪接

mRNA的可变剪接(alternative splicing)是一种由一个mRNA前体(pre-mRNA)通过不同的剪接方式产生多个mRNA变异体(variants)的RNA加工过程。在过去很长一段时间里,人们认为mRNA剪接过程是独立于转录过程的一个转录后RNA加工过程。然而,越来越多的实验证明mRNA剪接在很大程度上是与转录偶联发生的。因此,剪接调控会受到与转录相关因素的调控。本文将对染色质与mRNA剪接调控的相关性和染色质结构调控可变剪接的分子机制进行阐述。     

可变剪接的生物信息数据分析综述

前体mRNA的可变剪接是扩大真核生物蛋白质组多样性的重要基因调控机制。可变剪接的错误调节可以引起多种人类疾病。由于高通量技术的发展,生物信息学成为可变剪接研究的主要手段。本文总结了可变剪接在生物信息学领域的研究方法,同时也分析并预测了可变剪接的发展方向。     

哺乳动物细胞mRNA剪接调控的分子机制

mRNA的可变剪接是指一个单一的mRNA前体(pre-mRNA)经过不同的剪接加工方式生成多种mRNA变异体(variants)的过程,这些变异体最终可以编码合成具有不同结构和功能的蛋白质。在过去的10多年中,大量数据表明,可变剪接是增加转录组和蛋白质组多样性的重要资源,也是调控哺乳动物细胞基因表达的重要步骤。可变剪接具有高度的组织与发育阶段特异性,并受到外界信号的控制。剪接调控的紊乱与疾病的发生发展密切相关。该文将对哺乳动物细胞mRNA剪接调控的分子机制进行阐述。     

Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta

Mutations in the human tau gene leading to aberrant splicing have been identified in FTDP-17, an autosomal dominant hereditary neurodegenerative disorder. Molecular mechanisms by which such mutations cause tau aberrant splicing were not understood. We characterized two mutations in exon 10 of the tau gene, N279K and Del280K. Our results revealed an exonic splicing enhancer element located in exon 10. The activity of this AG-rich splicing enhancer was altered by N279K and Del280K mutations. This exonic enhancer element interacts with human Tra2 beta protein. The interaction between Tra2 beta and the exonic splicing enhancer correlates with the activity of this enhancer element in stimulating splicing. Biochemical studies including in vitro splicing and RNA interference experiments in transfected cells support a role for Tra2 beta protein in regulating alternative splicing of human tau gene. Our results implicate the human tau gene as a target gene for the alternative splicing regulator Tra2 beta, suggesting that Tra2 beta may play a role in aberrant tau exon 10 alternative splicing and in the pathogenesis of tauopathies.     

The haplo-spliceo-transcriptome: common variations in alternative splicing in the human population

Numerous inherited human genetic disorders are caused by defects in pre-mRNA splicing. Two recent studies have added a new twist to the link between genetic variation and pre-mRNA splicing by identifying SNPs that correlate with heritable changes in alternative splicing but do not cause disease. This suggests that allele-specific alternative splicing is a mechanism that accounts for individual variation in the human population.     

Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing

Aberrant or modified splicing patterns of genes are causative for many human diseases. Therefore, the identification of genetic variations that cause changes in the splicing pattern of a gene is important. Elsewhere, we described the widespread occurrence of alternative splicing at NAGNAG acceptors. Here, we report a genomewide screen for single-nucleotide polymorphisms (SNPs) that affect such tandem acceptors. From 121 SNPs identified, we extracted 64 SNPs that most likely affect alternative NAGNAG splicing. We demonstrate that the NAGNAG motif is necessary and sufficient for this type of alternative splicing. The evolutionarily young NAGNAG alleles, as determined by the comparison with the chimpanzee genome, exhibit the same biases toward intron phase 1 and single-amino acid insertion/deletions that were already observed for all human NAGNAG acceptors. Since 28% of the NAGNAG SNPs occur in known disease genes, they represent preferable candidates for a more-detailed functional analysis, especially since the splice relevance for some of the coding SNPs is overlooked. Against the background of a general lack of methods for identifying splice-relevant SNPs, the presented approach is highly effective in the prediction of polymorphisms that are causal for variations in alternative splicing.     

Biomedical impact of splicing mutations revealed through exome sequencing

Splicing is a cellular mechanism, which dictates eukaryotic gene expression by removing the noncoding introns and ligating the coding exons in the form of a messenger RNA molecule. Alternative splicing (AS) adds a major level of complexity to this mechanism and thus to the regulation of gene expression. This widespread cellular phenomenon generates multiple messenger RNA isoforms from a single gene, by utilizing alternative splice sites and promoting different exon-intron inclusions and exclusions. AS greatly increases the coding potential of eukaryotic genomes and hence contributes to the diversity of eukaryotic proteomes. Mutations that lead to disruptions of either constitutive splicing or AS cause several diseases, among which are myotonic dystrophy and cystic fibrosis. Aberrant splicing is also well established in cancer states. Identification of rare novel mutations associated with splice-site recognition, and splicing regulation in general, could provide further insight into genetic mechanisms of rare diseases. Here, disease relevance of aberrant splicing is reviewed, and the new methodological approach of starting from disease phenotype, employing exome sequencing and identifying rare mutations affecting splicing regulation is described. Exome sequencing has emerged as a reliable method for finding sequence variations associated with various disease states. To date, genetic studies using exome sequencing to find disease-causing mutations have focused on the discovery of nonsynonymous single nucleotide polymorphisms that alter amino acids or introduce early stop codons, or on the use of exome sequencing as a means to genotype known single nucleotide polymorphisms. The involvement of splicing mutations in inherited diseases has received little attention and thus likely occurs more frequently than currently estimated. Studies of exome sequencing followed by molecular and bioinformatic analyses have great potential to reveal the high impact of splicing mutations underlying human disease.